Corteva (CTVA) Stock Forecast & Price Target

$57.48 +1.32 (+2.35%)

(As of 12/20/2024 05:31 PM ET)

Corteva - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
1

Hold
4

Buy
14

Based on 19 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 1 has given a sell rating, 4 have given a hold rating, and 14 have given a buy rating for CTVA.

Consensus Price Target

$65.41
13.80% Upside

According to the 19 analysts' twelve-month price targets for Corteva, the average price target is $65.41. The highest price target for CTVA is $73.00, while the lowest price target for CTVA is $53.00. The average price target represents a forecasted upside of 13.80% from the current price of $57.48.

Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

CTVA Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	15 Buy rating(s)	13 Buy rating(s)	16 Buy rating(s)
Hold	4 Hold rating(s)	5 Hold rating(s)	6 Hold rating(s)	5 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$65.41	$64.26	$61.67	$64.65
Forecasted Upside	13.80% Upside	5.49% Upside	7.10% Upside	36.22% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Corteva Stock vs. The Competition

Type	Corteva	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.68	2.50	2.51
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	13.80% Upside	46.09% Upside	14.53% Upside
News Sentiment Rating	Positive News See Recent CTVA News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/19/2024	Royal Bank of Canada 4 of 5 stars		Boost Target	Outperform ➝ Outperform	$68.00 ➝ $73.00	+29.25%
12/18/2024	Citigroup 3 of 5 stars	P. Cunningham Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$70.00 ➝ $69.00	+17.33%
11/21/2024	KeyCorp 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$66.00 ➝ $69.00	+17.41%
11/20/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$67.00 ➝ $69.00	+18.97%
11/20/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$65.00 ➝ $67.00	+15.52%
11/8/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$58.00 ➝ $62.00	+5.93%
Get the Latest News and Ratings for CTVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corteva and its competitors with MarketBeat's FREE daily newsletter.
11/8/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$69.00 ➝ $70.00	+18.02%
11/7/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$67.00 ➝ $71.00	+23.07%
9/24/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$65.00 ➝ $65.00	+12.67%
8/7/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Selesky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/2/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$57.00 ➝ $55.00	+6.63%
6/18/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$61.00 ➝ $60.00	+15.27%
6/12/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$65.00 ➝ $65.00	+25.90%
6/7/2024	OTR Global Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Mixed ➝ Negative
5/3/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$60.00 ➝ $65.00	+13.72%
5/3/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$64.00 ➝ $67.00	+17.13%
3/1/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$67.00	+25.30%
2/12/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$57.00 ➝ $65.00	+21.27%
2/2/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Neutral	$53.00	-1.96%
11/27/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$63.00 ➝ $52.00	+11.42%
11/22/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$82.00 ➝ $63.00	+36.45%
10/24/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$65.00 ➝ $56.00	+15.08%
8/4/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$74.00	+31.95%
7/25/2023	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
5/22/2023	VNET Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Upgrade
5/22/2023	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$67.00	+17.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:17 PM ET.

Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

Here are some ways that investors could benefit from investing in Corteva, Inc.:

Corteva, Inc. has a strong consensus rating of "Moderate Buy" from analysts, indicating positive sentiment towards the stock's future performance.
The company recently announced a share repurchase program authorizing the buyback of up to $3.00 billion in shares, which suggests that management believes the stock is undervalued and can enhance shareholder value.
As of the latest trading session, Corteva, Inc. stock is priced at $62.26, which is near its 12-month high of $64.20, indicating strong market performance.
The company has a solid dividend yield of 1.09%, with a quarterly dividend of $0.17 per share, providing a steady income stream for investors.
Recent target price increases from major financial institutions, such as Bank of America raising it to $69.00, reflect growing confidence in Corteva's growth potential.

Corteva
Bear Case

Investors should be bearish about investing in Corteva, Inc. for these reasons:

JPMorgan Chase & Co. recently lowered their target price for Corteva from $57.00 to $55.00, indicating a more cautious outlook on the stock.
One analyst has rated Corteva with a sell rating, which could signal potential risks or concerns about the company's future performance.
The stock has a relatively high price-to-earnings (P/E) ratio of 63.13, suggesting that it may be overvalued compared to its earnings, which could deter value-focused investors.
Corteva's quick ratio of 0.96 indicates that the company may have difficulty meeting its short-term liabilities, which could raise concerns about liquidity.
Despite the positive sentiment, the stock's beta of 0.77 suggests lower volatility compared to the market, which may not appeal to investors seeking high-growth opportunities.

CTVA Forecast - Frequently Asked Questions

: According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $65.41, with a high forecast of $73.00 and a low forecast of $53.00.
: 19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There is currently 1 sell rating, 4 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CTVA shares.
: According to analysts, Corteva's stock has a predicted upside of 13.80% based on their 12-month stock forecasts.
: Over the previous 90 days, Corteva's stock had 1 upgrade by analysts.
: Corteva has been rated by research analysts at Bank of America, Barclays, Citigroup, KeyCorp, Morgan Stanley, Oppenheimer, Royal Bank of Canada, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Corteva more than other "consumer staples" companies. The consensus rating for Corteva is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CTVA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

>> Register for the Workshop Now

This page (NYSE:CTVA) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corteva (CTVA) Stock Forecast & Price Target